| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 720248 | Null | 0.0420420371076614 | 0.17099173 |
| NSC 722222 | Null | 0.0420420371076614 | 0.34236981 |
| NSC 728037 | 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline | 0.0420420371076614 | 0.49002111 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0420420371076614 | -0.093017276 |
| NSC 736200 | 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline | 0.0420420371076614 | 0.30711901 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0420420371076614 | 0.52338836 |
| NSC 750440 | Null | 0.0420420371076614 | 0.18872392 |
| NSC 753190 | 3,5-dichloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide | 0.0420420371076614 | 0.29352585 |
| NSC 756166 | GSK312948A | 0.0420420371076614 | 0.37173287 |
| NSC 761980 | Null | 0.0420420371076614 | 0.25196625 |